Hester Biosciences, 524669, HESTERBIO Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,199.47
29.29
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,399.15
0.50%
3.47

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.92
7.74
5.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.22
-2.32
3.91

PAT CAGR (%)

10 Years
5 Years
3 Years

3.66
-4.40
1.07

P:E (Median)

8 Years
5 Years
3 Years

49.89
52.37
52.33

P:BV (Average)

8 Years
5 Years
3 Years

6.64
6.24
5.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.10
26.99
26.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 70.35 62.83 11.97% 64.58 73.50 -12.14% 63.49 73.47 -13.58% 76.67 72.87 5.21%
Expenses 53.64 53.81 -0.32% 52.70 58.77 -10.33% 51.08 59.97 -14.82% 62.97 60.46 4.15%
EBITDA 16.72 9.01 85.57% 11.88 14.73 -19.35% 12.41 13.50 -8.07% 13.70 12.41 10.39%
EBIDTM 23.76% 14.35% 18.40% 20.04% 19.55% 18.37% 17.87% 17.04%
Other Income 1.03 1.30 -20.77% 1.48 1.35 9.63% 0.95 1.06 -10.38% 1.06 1.20 -11.67%
Interest 0.90 1.59 -43.40% 1.27 1.40 -9.29% 0.91 1.13 -19.47% 1.25 1.31 -4.58%
Depreciation 2.21 2.24 -1.34% 2.20 2.19 0.46% 2.16 2.12 1.89% 2.03 2.08 -2.40%
PBT 14.64 6.49 125.58% 9.88 12.48 -20.83% 10.29 11.30 -8.94% 11.48 10.22 12.33%
Tax 3.97 2.05 93.66% 2.67 3.15 -15.24% 2.45 2.87 -14.63% 1.85 2.79 -33.69%
PAT 10.67 4.44 140.32% 7.21 9.34 -22.81% 7.84 8.43 -7.00% 9.63 7.43 29.61%
PATM 15.16% 7.07% 11.16% 12.70% 12.35% 11.48% 12.57% 10.20%
EPS 12.55 5.22 140.42% 8.48 10.98 -22.77% 9.22 9.92 -7.06% 11.34 8.74 29.75%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 77.41 63.22 22.45% 70.97 83.69 -15.20% 84.10 82.27 2.22% 81.92 79.25 3.37%
Expenses 59.62 58.16 2.51% 59.25 64.53 -8.18% 61.29 64.62 -5.15% 62.74 63.33 -0.93%
EBITDA 17.79 5.06 251.58% 11.72 19.16 -38.83% 22.81 17.65 29.24% 19.18 15.92 20.48%
EBIDTM 22.98% 8.01% 16.51% 22.89% 27.13% 21.45% 23.41% 20.09%
Other Income 0.67 7.81 -91.42% 9.73 1.84 428.80% 2.32 1.23 88.62% -6.95 4.15 -
Interest 1.82 -3.81 - 2.21 5.89 -62.48% 1.81 5.01 -63.87% 5.62 6.94 -19.02%
Depreciation 4.43 4.29 3.26% 4.35 4.20 3.57% 4.18 4.13 1.21% 4.18 3.74 11.76%
PBT 12.21 12.39 -1.45% 14.88 10.91 36.39% 19.14 9.73 96.71% 2.44 9.39 -74.01%
Tax 4.21 1.96 114.80% 2.71 3.48 -22.13% 2.89 3.11 -7.07% 2.20 3.47 -36.60%
PAT 8.00 10.43 -23.30% 12.18 7.44 63.71% 16.25 6.63 145.10% 0.23 5.91 -96.11%
PATM 10.33% 16.50% 17.16% 8.88% 19.32% 8.05% 0.28% 7.46%
EPS 10.30 13.71 -24.87% 16.98 9.64 76.14% 19.33 7.45 159.46% 1.52 5.82 -73.88%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 275.09 286.47 285.15 254.00 219.35 208.48 169.43 171.19 134.79 123.28 100.89 Net Sales Growth -2.68% 0.46% 12.26% 15.80% 5.21% 23.05% -1.03% 27.00% 9.34% 22.19% Cost Of Goods Sold 87.55 93.65 99.64 79.88 63.84 53.39 29.24 29.21 23.31 29.89 19.75 Gross Profit 187.54 192.81 185.51 174.12 155.51 155.08 140.19 141.97 111.47 93.39 81.14 GP Margin 68.17% 67.31% 65.06% 68.55% 70.90% 74.39% 82.74% 82.93% 82.70% 75.75% 80.42% Total Expenditure 220.39 235.52 238.30 199.32 158.78 136.48 116.70 103.42 85.19 82.21 67.50 Power & Fuel Cost - 10.12 12.34 9.95 8.74 6.93 7.29 7.08 5.84 5.31 5.81 % Of Sales - 3.53% 4.33% 3.92% 3.98% 3.32% 4.30% 4.14% 4.33% 4.31% 5.76% Employee Cost - 54.76 56.72 47.92 39.12 33.45 37.16 26.74 22.29 18.32 15.44 % Of Sales - 19.12% 19.89% 18.87% 17.83% 16.04% 21.93% 15.62% 16.54% 14.86% 15.30% Manufacturing Exp. - 15.62 15.20 10.54 10.17 10.79 11.31 10.95 9.24 6.97 7.85 % Of Sales - 5.45% 5.33% 4.15% 4.64% 5.18% 6.68% 6.40% 6.86% 5.65% 7.78% General & Admin Exp. - 26.01 24.92 21.60 14.50 13.24 16.34 11.77 12.92 11.35 10.23 % Of Sales - 9.08% 8.74% 8.50% 6.61% 6.35% 9.64% 6.88% 9.59% 9.21% 10.14% Selling & Distn. Exp. - 26.89 24.63 24.68 17.16 13.68 11.42 16.02 9.09 8.15 6.77 % Of Sales - 9.39% 8.64% 9.72% 7.82% 6.56% 6.74% 9.36% 6.74% 6.61% 6.71% Miscellaneous Exp. - 8.46 4.86 4.76 5.26 5.00 3.95 1.65 2.50 2.22 6.77 % Of Sales - 2.95% 1.70% 1.87% 2.40% 2.40% 2.33% 0.96% 1.85% 1.80% 1.63% EBITDA 54.71 50.95 46.85 54.68 60.57 72.00 52.73 67.77 49.60 41.07 33.39 EBITDA Margin 19.89% 17.79% 16.43% 21.53% 27.61% 34.54% 31.12% 39.59% 36.80% 33.31% 33.10% Other Income 4.52 4.76 4.75 5.53 4.66 1.65 2.93 3.10 1.88 0.73 0.87 Interest 4.33 5.37 5.09 6.50 2.47 3.95 5.03 3.54 2.32 3.21 3.69 Depreciation 8.60 8.58 9.78 9.79 9.50 9.63 9.38 7.57 5.45 5.51 5.73 PBT 46.29 41.76 36.73 43.92 53.26 60.06 41.23 59.75 43.71 33.09 24.85 Tax 10.94 9.92 9.57 11.58 13.74 14.88 10.01 15.90 13.15 8.15 5.63 Tax Rate 23.63% 23.75% 26.05% 26.37% 25.80% 27.16% 24.28% 26.61% 30.08% 24.63% 22.66% PAT 35.35 31.84 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 PAT before Minority Interest 35.35 31.84 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.85% 11.11% 9.52% 12.73% 18.02% 19.14% 18.43% 25.61% 22.67% 20.23% 19.05% PAT Growth 19.26% 17.23% -16.02% -18.17% -0.95% 27.80% -28.80% 43.49% 22.53% 29.76% EPS 41.59 37.46 31.95 38.05 46.49 46.94 36.73 51.59 35.95 29.34 22.61

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 314.40 311.10 304.55 266.09 235.01 214.33 183.27 178.07 135.94 123.11 100.89 Net Sales Growth 1.94% 2.15% 14.45% 13.22% 9.65% 16.95% 2.92% 30.99% 10.42% 22.02% Cost Of Goods Sold 83.24 88.33 95.88 77.49 64.85 50.23 27.98 28.47 23.31 28.45 19.75 Gross Profit 231.16 222.78 208.67 188.60 170.15 164.11 155.29 149.60 112.63 94.65 81.14 GP Margin 73.53% 71.61% 68.52% 70.88% 72.40% 76.57% 84.73% 84.01% 82.85% 76.88% 80.42% Total Expenditure 242.90 250.05 251.38 215.69 175.02 145.67 127.87 110.03 88.68 82.09 67.50 Power & Fuel Cost - 13.98 15.30 12.74 10.28 7.57 8.13 7.83 6.37 5.59 5.81 % Of Sales - 4.49% 5.02% 4.79% 4.37% 3.53% 4.44% 4.40% 4.69% 4.54% 5.76% Employee Cost - 62.42 64.13 56.02 45.33 38.92 40.65 28.93 23.24 18.32 15.44 % Of Sales - 20.06% 21.06% 21.05% 19.29% 18.16% 22.18% 16.25% 17.10% 14.88% 15.30% Manufacturing Exp. - 18.05 17.13 12.67 11.51 11.60 11.98 11.34 9.45 7.06 7.85 % Of Sales - 5.80% 5.62% 4.76% 4.90% 5.41% 6.54% 6.37% 6.95% 5.73% 7.78% General & Admin Exp. - 29.64 27.17 24.89 19.20 15.29 13.47 13.72 13.81 11.47 10.23 % Of Sales - 9.53% 8.92% 9.35% 8.17% 7.13% 7.35% 7.70% 10.16% 9.32% 10.14% Selling & Distn. Exp. - 28.28 25.60 26.34 17.31 14.73 18.97 16.77 9.11 8.15 6.77 % Of Sales - 9.09% 8.41% 9.90% 7.37% 6.87% 10.35% 9.42% 6.70% 6.62% 6.71% Miscellaneous Exp. - 9.36 6.18 5.54 6.53 7.34 6.69 2.98 3.40 3.05 6.77 % Of Sales - 3.01% 2.03% 2.08% 2.78% 3.42% 3.65% 1.67% 2.50% 2.48% 1.63% EBITDA 71.50 61.05 53.17 50.40 59.99 68.66 55.40 68.04 47.26 41.02 33.39 EBITDA Margin 22.74% 19.62% 17.46% 18.94% 25.53% 32.03% 30.23% 38.21% 34.77% 33.32% 33.10% Other Income 5.77 3.92 11.13 15.36 13.74 4.68 6.37 7.21 2.55 0.42 0.88 Interest 11.46 12.70 19.77 9.32 4.06 6.60 7.37 6.63 4.04 3.50 3.72 Depreciation 17.14 16.80 17.17 20.70 16.58 13.31 13.07 11.76 9.66 7.00 5.75 PBT 48.67 35.47 27.34 35.74 53.08 53.42 41.33 56.86 36.12 30.93 24.81 Tax 12.01 10.74 10.79 12.12 14.02 15.40 10.32 16.16 13.05 8.15 5.63 Tax Rate 24.68% 30.28% 39.47% 33.91% 26.41% 30.74% 24.97% 28.42% 36.13% 26.35% 22.69% PAT 36.66 27.49 18.89 26.63 39.32 34.43 29.17 41.56 25.62 23.55 19.19 PAT before Minority Interest 35.13 28.83 21.17 28.04 39.48 34.70 31.00 40.69 23.07 22.79 19.18 Minority Interest -1.53 -1.34 -2.28 -1.41 -0.16 -0.27 -1.83 0.87 2.55 0.76 0.01 PAT Margin 11.66% 8.84% 6.20% 10.01% 16.73% 16.06% 15.92% 23.34% 18.85% 19.13% 19.02% PAT Growth 20.55% 45.53% -29.06% -32.27% 14.20% 18.03% -29.81% 62.22% 8.79% 22.72% EPS 43.13 32.34 22.22 31.33 46.26 40.51 34.32 48.89 30.14 27.71 22.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 339.09 312.71 292.38 268.43 237.58 203.08 179.44 146.08 122.09 100.32 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 330.58 304.20 283.88 259.93 229.07 194.57 170.93 137.57 113.58 91.81 Non-Current Liabilities 110.21 139.11 116.96 81.17 9.79 15.89 21.51 21.98 22.36 21.05 Secured Loans 51.31 79.07 83.40 73.25 2.68 7.45 11.37 14.61 18.66 12.87 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.38 2.26 1.72 1.08 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 96.70 97.72 136.47 74.84 34.65 58.22 39.30 42.43 33.99 37.45 Trade Payables 32.53 29.68 28.71 11.03 14.03 13.61 8.05 7.85 7.47 5.84 Other Current Liabilities 30.86 35.58 46.59 29.34 15.11 12.37 10.05 9.33 7.82 8.55 Short Term Borrowings 28.64 29.79 57.34 33.29 1.71 31.80 20.94 24.19 17.51 21.04 Short Term Provisions 4.67 2.67 3.83 1.18 3.81 0.44 0.26 1.06 1.18 2.02 Total Liabilities 546.00 549.54 545.81 424.44 282.02 277.19 240.25 210.49 178.44 158.82 Net Block 105.46 103.46 108.22 84.31 86.69 96.76 100.81 66.74 60.85 61.57 Gross Block 212.38 203.62 199.00 171.17 164.64 166.61 161.97 120.89 109.55 105.07 Accumulated Depreciation 106.92 100.16 90.78 86.86 77.95 69.85 61.02 54.15 48.70 43.50 Non Current Assets 360.76 345.13 329.77 257.97 142.41 154.01 140.84 121.36 103.63 91.64 Capital Work in Progress 182.70 171.40 148.61 81.91 3.72 0.87 0.42 30.47 21.29 10.47 Non Current Investment 64.69 64.69 64.69 64.69 43.88 40.67 28.22 14.48 8.60 8.67 Long Term Loans & Adv. 6.30 4.85 6.83 24.20 5.32 11.83 9.81 9.59 12.41 10.93 Other Non Current Assets 1.61 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 Current Assets 185.24 204.41 216.05 166.47 139.61 123.18 99.40 89.13 74.81 67.18 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 58.51 68.53 79.22 70.73 57.01 60.43 48.50 38.70 33.07 33.62 Sundry Debtors 80.59 85.78 82.36 56.92 45.55 44.76 32.67 31.94 26.71 26.24 Cash & Bank 2.18 4.96 5.96 1.98 1.24 5.19 2.49 11.95 11.48 5.26 Other Current Assets 43.96 5.36 5.45 2.83 35.80 12.80 15.74 6.54 3.56 2.07 Short Term Loans & Adv. 36.80 39.78 43.06 34.01 29.50 11.84 12.95 5.69 3.30 2.07 Net Current Assets 88.53 106.69 79.58 91.64 104.96 64.96 60.10 46.70 40.82 29.73 Total Assets 546.00 549.54 545.82 424.44 282.02 277.19 240.24 210.49 178.44 158.82

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 314.25 291.79 279.73 259.99 228.31 201.07 177.46 140.63 121.95 101.71 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 305.75 283.29 271.22 251.48 219.80 192.56 168.95 132.13 113.44 93.20 Non-Current Liabilities 201.54 254.00 232.72 197.87 113.72 96.64 69.64 44.41 48.32 41.28 Secured Loans 133.37 182.09 184.85 164.54 82.84 76.48 58.35 36.54 44.62 33.09 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.75 2.53 1.93 1.27 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 125.18 105.47 148.70 96.90 61.37 83.46 48.66 54.63 38.01 38.20 Trade Payables 29.42 25.86 29.98 18.02 28.09 20.02 8.75 7.90 7.47 5.84 Other Current Liabilities 61.14 45.05 55.96 42.81 22.52 30.44 17.15 20.26 11.04 9.30 Short Term Borrowings 29.58 31.35 58.86 34.84 3.28 32.54 22.50 25.41 18.32 21.04 Short Term Provisions 5.05 3.22 3.90 1.22 7.48 0.46 0.26 1.07 1.18 2.02 Total Liabilities 653.37 662.34 669.97 562.17 411.05 386.59 299.46 244.04 212.88 185.84 Net Block 233.31 240.11 259.37 237.17 132.76 142.54 144.82 110.22 102.62 64.63 Gross Block 390.00 382.04 385.80 348.16 228.12 226.04 215.94 170.22 152.95 108.25 Accumulated Depreciation 156.69 141.93 126.43 110.99 95.36 83.50 70.98 60.00 50.33 43.62 Non Current Assets 458.21 447.73 442.37 367.40 249.54 227.29 157.80 145.59 132.91 111.63 Capital Work in Progress 182.70 171.40 148.61 81.91 109.17 74.15 7.05 31.81 21.29 36.46 Non Current Investment 34.05 29.93 25.30 21.24 0.00 0.00 0.00 0.00 0.00 0.07 Long Term Loans & Adv. 6.54 5.55 7.67 24.22 4.82 6.74 4.34 3.48 8.52 10.47 Other Non Current Assets 1.61 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 Current Assets 195.17 214.62 227.59 194.76 161.50 159.31 141.66 98.45 79.97 74.20 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 70.38 75.58 84.81 75.38 62.22 63.97 50.79 39.76 33.41 33.62 Sundry Debtors 73.18 78.64 79.63 55.28 49.21 58.44 32.87 32.29 26.53 26.24 Cash & Bank 7.22 15.30 14.82 25.20 21.27 23.53 41.05 13.39 11.48 5.28 Other Current Assets 44.39 5.81 6.02 5.20 28.80 13.37 16.95 13.01 8.54 9.05 Short Term Loans & Adv. 36.88 39.27 42.31 33.70 26.24 8.19 11.32 8.95 5.06 2.49 Net Current Assets 69.99 109.14 78.90 97.87 100.14 75.84 92.99 43.82 41.95 36.00 Total Assets 653.38 662.35 669.96 562.16 411.04 386.60 299.46 244.04 212.88 185.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 63.97 42.86 33.36 15.90 41.10 25.82 36.19 32.28 27.55 18.64 PBT 41.76 36.73 43.92 53.26 54.78 41.23 59.75 43.71 33.09 24.85 Adjustment 15.82 13.32 14.55 11.70 19.61 12.25 8.50 7.34 8.74 9.31 Changes in Working Capital 16.31 3.84 -17.05 -32.61 -19.80 -16.31 -16.47 -9.37 -7.22 -9.54 Cash after chg. in Working capital 73.89 53.89 41.43 32.34 54.59 37.17 51.78 41.67 34.61 24.62 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.92 -11.03 -8.06 -16.44 -13.49 -11.35 -15.58 -9.39 -7.06 -5.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -19.04 -20.59 -71.96 -110.58 -3.72 -21.33 -24.70 -26.32 -15.49 -5.68 Net Fixed Assets -20.06 -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 Net Investments 0.00 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 Others 1.02 6.82 22.57 -5.05 0.37 -3.79 0.07 0.08 -0.26 0.98 Cash from Financing Activity -46.35 -24.12 41.38 94.96 -41.33 -1.39 -20.29 -6.24 -5.60 -11.92 Net Cash Inflow / Outflow -1.42 -1.85 2.77 0.28 -3.95 3.10 -8.80 -0.28 6.46 1.04 Opening Cash & Equivalents 1.97 3.81 1.53 1.24 5.19 2.09 10.89 11.17 4.71 3.92 Closing Cash & Equivalent 0.55 1.97 4.30 1.53 1.24 5.19 2.09 10.89 11.17 4.96

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 64.51 48.18 23.60 8.71 58.05 36.77 46.71 38.02 34.80 18.85 PBT 39.57 31.95 40.15 53.50 50.10 41.33 56.86 36.12 30.93 24.81 Adjustment 26.47 24.22 12.39 11.10 20.34 20.13 17.92 13.63 10.86 9.38 Changes in Working Capital 9.95 3.67 -20.84 -38.78 1.54 -13.75 -12.26 -2.31 0.11 -9.37 Cash after chg. in Working capital 75.98 59.85 31.70 25.82 71.99 47.71 62.52 47.44 41.90 24.82 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.47 -11.67 -8.11 -17.11 -13.94 -10.94 -15.81 -9.41 -7.06 -5.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 Cash From Investing Activity -19.00 -22.61 -77.00 -116.59 -38.37 -74.47 -21.73 -25.83 -30.19 -13.30 Net Fixed Assets -20.06 -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 Net Investments 0.00 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 Others 1.06 4.80 17.53 -11.06 -34.28 -56.93 3.04 0.57 -14.96 -6.64 Cash from Financing Activity -51.72 -26.09 41.76 111.54 -18.22 18.74 2.65 -11.08 1.83 -6.68 Net Cash Inflow / Outflow -6.21 -0.52 -11.64 3.66 1.46 -18.96 27.63 1.12 6.45 -1.14 Opening Cash & Equivalents 12.31 12.67 24.75 21.27 23.53 40.65 12.33 11.18 4.73 6.12 Closing Cash & Equivalent 5.59 12.31 13.16 24.75 21.27 23.53 40.65 12.33 11.18 4.99

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 398.60 367.59 343.70 315.54 279.28 238.72 210.93 171.72 143.52 117.93 ROA 5.81% 4.96% 6.67% 11.19% 14.27% 12.07% 19.46% 15.71% 14.79% 12.85% ROE 9.77% 8.98% 11.53% 15.62% 18.11% 16.33% 26.94% 22.79% 22.43% 20.83% ROCE 10.59% 9.26% 11.91% 17.31% 23.28% 19.74% 31.15% 26.28% 24.16% 21.79% Fixed Asset Turnover 1.38 1.42 1.38 1.32 1.26 1.03 1.21 1.17 1.17 1.03 Receivable days 105.93 107.52 99.32 84.52 79.06 83.41 68.88 79.13 76.95 77.96 Inventory Days 80.88 94.48 106.93 105.37 102.81 117.33 92.96 96.84 96.91 111.14 Payable days 121.23 106.95 90.79 71.61 94.44 36.28 28.05 36.46 33.72 29.57 Cash Conversion Cycle 65.58 95.05 115.46 118.28 87.43 164.47 133.79 139.51 140.15 159.53 Total Debt/Equity 0.31 0.43 0.56 0.45 0.07 0.24 0.21 0.29 0.32 0.39 Interest Cover 8.78 8.21 7.76 22.58 14.88 9.19 17.87 19.88 11.31 7.74

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 369.41 343.00 328.82 305.61 268.38 236.36 208.61 165.32 143.35 119.56 ROA 4.38% 3.18% 4.55% 8.11% 8.70% 9.04% 14.97% 10.10% 11.43% 11.08% ROE 9.51% 7.41% 10.39% 16.17% 16.16% 16.38% 25.59% 17.57% 20.38% 20.56% ROCE 9.93% 9.59% 9.60% 14.12% 17.33% 16.53% 26.64% 20.20% 19.75% 18.98% Fixed Asset Turnover 0.81 0.79 0.73 0.82 0.95 0.83 0.92 0.84 0.96 1.00 Receivable days 89.02 94.77 91.87 80.50 91.49 90.92 66.77 78.70 76.80 77.96 Inventory Days 85.58 96.04 109.08 106.00 107.25 114.27 92.80 97.89 97.55 111.14 Payable days 114.21 106.28 113.04 129.73 174.82 42.10 27.25 33.70 33.48 29.56 Cash Conversion Cycle 60.38 84.54 87.91 56.77 23.92 163.09 132.33 142.89 140.87 159.54 Total Debt/Equity 0.66 0.82 0.96 0.86 0.46 0.60 0.51 0.49 0.54 0.58 Interest Cover 4.12 2.62 5.31 14.16 8.59 6.61 9.57 9.95 9.84 7.67

Top Investors:

kuntal hasmukhlal shah

manish jain

darshna dinesh kapadia

vinay shah

manish jain (huf)

manish prataprai gandhi

jagrut prataprai gandhi

sandeep shantilal gala

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Hester Biosciences gets nod to divest 43.81% stake in Texas Lifesciences
11th Mar 2026, 12:17 PM

The transaction is expected to be completed within three months
Read More
Hester Biosciences - Quarterly Results
31st Jan 2026, 00:00 AM

Read More
Hester gets manufacturing license for Inactivated Avian Influenza Vaccine for poultry
27th Jan 2026, 09:59 AM

This vaccine has been developed from technology acquired from ICAR-NIHSAD via Agrinnovate India
Read More

Hester Biosciences Ltd.

Pharmaceuticals & Drugs - Veterinary

BSE: 524669 | NSE: HESTERBIO

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Hester Biosciences Ltd.

Pharmaceuticals & Drugs - Veterinary

BSE: 524669 | NSE: HESTERBIO

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: